Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes

March 6, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA has authorized 23andMe to market a consumer test that reports only 3 out of more than 1,000 known mutations in BRCA genes

Post navigation

← IDLife, LLC Issues Allergy Alert on Various Undeclared Allergens in its Bars Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results →
Proudly powered by WordPress